Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2022 - 03 - 08    symbols : NVS    save search

Voyager Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
Published: 2022-03-08 (Crawled : 17:00) - voyagertherapeutics.com
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -4.98% H: 0.0% C: 0.0%
VYGR | $7.5 -0.66% -0.67% 520K twitter stocktwits trandingview |
Health Technology
| | O: 31.15% H: 19.58% C: 9.17%

therapeutics report results
Global RNA-Targeted Small Molecules Market to Witness 6.1% Growth during 2022 - 2030
Published: 2022-03-08 (Crawled : 16:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -4.98% H: 0.0% C: 0.0%

growth
Non-small Cell Lung Cancer Drugs Market to Grow by USD 30.23 billion| Increasing Prevalence and Incidence of Non-small Cell Lung Cancer to Boost Market Growth | Technavio
Published: 2022-03-08 (Crawled : 08:00) - prnewswire.com
AZNCF | $138.24 -4.19% 800 twitter stocktwits trandingview |
Health Technology
| | O: -2.09% H: 5.03% C: 0.85%
ALPMY | $9.47 -1.11% 520K twitter stocktwits trandingview |
Manufacturing
| | O: 1.01% H: 0.81% C: -0.06%
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -4.98% H: 0.0% C: 0.0%
ABBV | News | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.29% H: 0.6% C: -1.24%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 3.03% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.44% H: 0.0% C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.35% H: 0.0% C: 0.0%

drug cel lung cancer cancer drug cancer growth
Voyager Therapeutics Announces License Option Agreement with Novartis for Target-Specific Access to Next-Generation TRACER™ AAV Capsids for Gene Therapy Programs
Published: 2022-03-08 (Crawled : 07:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -4.98% H: 0.0% C: 0.0%
VYGR | $7.5 -0.66% -0.67% 520K twitter stocktwits trandingview |
Health Technology
| | O: 31.15% H: 19.58% C: 9.17%

trace novartis aav capsids gene therapy program license therapeutics therapy
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | News | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.